Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

FGF-21 as a novel metabolic regulator

Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester et al. · Journal of Clinical Investigation · 2005 · 2.1K citations · Full text

Obesity, Metabolic Syndrome, Novel Metabolic Regulator +14

Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21

Takeshi Inagaki, Paul A. Dutchak, Guixiang Zhao et al. · Cell Metabolism · 2007 · 1.5K citations · Full text

Molecular Physiology, Growth Hormone, Endocrine Mechanism +11

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale et al. · Diabetes · 2008 · 1.1K citations · Full text

Fibroblast Growth Factor 21 Corrects Obesity in Mice

Tamer Coşkun, Holly A. Bina, M. Schneider et al. · Endocrinology · 2008 · 1K citations

Nutrition, Metabolic Disorder, Corrects Obesity +23

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

Gregory Gaich, Jenny Y. Chien, Haoda Fu et al. · Cell Metabolism · 2013 · 867 citations · Full text

Obesity, Metabolic Syndrome, Health Sciences +10